Netherlands Diabetes Care Devices Market Outlook to 2018-Glucose Monitoring and Insulin DeliveryReport Details:Published:S...
Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth....
5.2 Insulin Delivery Market, Netherlands, Revenue Mix ($m), 2011 435.3 Insulin Delivery Market, Netherlands, Segment Contr...
6.13 Terumo Corporation 796.13.1 Company Overview 797 Diabetes Care Devices Market Pipeline Products 808 Financial Deals L...
Table 11: Blood Glucose Meters, Netherlands, Revenue ($m*) USD Constant, by Sub-Segment,Forecast, 2011-2018 31Table 12: Gl...
1.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 10Figure 2: Diabetes Care Devices, Netherlands, Ov...
2004-2011 53Figure 29: Insulin Pumps, Netherlands, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 55Figure ...
Upcoming SlideShare
Loading in …5
×

Netherlands Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

173 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
173
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Netherlands Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

  1. 1. Netherlands Diabetes Care Devices Market Outlook to 2018-Glucose Monitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 92Price: Single User License – US$2500Netherlands Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and InsulinDeliverySummaryGlobalData’s new report, “Netherlands Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin Delivery” provides key market data on the Netherlands Diabetes CareDevices market. The report provides value (USD million), volume (units) and average price (USD)data for each segment and sub-segment within two market categories – Glucose Monitoring andInsulin Delivery. The report also provides company shares and distribution shares data for each ofthe aforementioned market categories. The report is supplemented with global corporate-levelprofiles of the key market participants with information on company financials and pipelineproducts, wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Netherlands Diabetes CareDevicesmarket.- Key players covered include F. Hoffmann-La Roche Ltd., Medtronic, Inc., Sanofi, Novo NordiskA/S, LifeScan, Inc., Eli Lilly and Company and others.
  2. 2. Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Netherlands Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197493-netherlands-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 51.2 List of Figures 72 Introduction 92.1 What is This Report About? 93 Diabetes Care Devices In Netherlands 103.1 Diabetes Care Devices, Market Segmentation 103.2 Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Constant, 2004-2018 113.3 Diabetes Care Devices Market, Netherlands, Revenue Mix ($m), 2011 123.4 Diabetes Care Devices Market, Netherlands, Category Contribution (%), 2011 133.5 Diabetes Care Devices, Netherlands, Company Share (2010-2011) 194 Glucose Monitoring In Netherlands 214.1 Glucose Monitoring, Market Segmentation 214.2 Glucose Monitoring Market, Netherlands, Revenue Mix ($m), 2011 224.3 Glucose Monitoring Market, Netherlands, Segment Contribution (%), 2011 234.4 Glucose Monitoring Overall Revenue, (2004-2018) 244.4.1 Blood Glucose Meters, Revenue (2004-2018) 284.5 Glucose Monitoring Overall Volume (2004-2018) 324.5.1 Blood Glucose Meters, Volume (2004-2018) 364.6 Glucose Monitoring Average Price (2004-2018) 384.7 Glucose Monitoring Distribution Share (2010-2011) 394.8 Glucose Monitoring, Netherlands, Company Share (2010-2011) 405 Insulin Delivery In Netherlands 425.1 Insulin Delivery, Market Segmentation 42
  3. 3. 5.2 Insulin Delivery Market, Netherlands, Revenue Mix ($m), 2011 435.3 Insulin Delivery Market, Netherlands, Segment Contribution (%), 2011 445.4 Insulin Delivery Overall Revenue, (2004-2018) 455.4.1 Insulin Pens, Revenue (2004-2018) 495.4.2 Insulin Pumps, Revenue (2004-2018) 535.5 Insulin Delivery Overall Volume (2004-2018) 575.5.1 Insulin Pens, Volume (2004-2018) 615.5.2 Insulin Pumps, Volume (2004-2018) 655.6 Insulin Delivery Average Price (2004-2018) 675.7 Insulin Delivery Distribution Share (2010-2011) 685.8 Insulin Delivery, Netherlands, Company Share (2010-2011) 696 Overview of Key Companies in Netherlands Diabetes Care Devices Market 716.1 F. Hoffmann-La Roche Ltd. 716.1.1 Company Overview 716.1.2 Share in the Netherlands Diabetes Care Devices Market 716.2 Medtronic, Inc. 726.2.1 Company Overview 726.2.2 Share in the Netherlands Diabetes Care Devices Market 726.3 Sanofi 736.3.1 Company Overview 736.3.2 Share in the Netherlands Diabetes Care Devices Market 736.4 Novo Nordisk A/S 746.4.1 Company Overview 746.4.2 Share in the Netherlands Diabetes Care Devices Market 746.5 LifeScan, Inc. 756.5.1 Company Overview 756.5.2 Share in the Netherlands Diabetes Care Devices Market 756.6 Eli Lilly and Company 766.6.1 Company Overview 766.6.2 Share in the Netherlands Diabetes Care Devices Market 766.7 Bayer HealthCare AG 776.7.1 Company Overview 776.8 A. Menarini Diagnostics S.r.l. 776.8.1 Company Overview 776.9 Abbott Laboratories 776.9.1 Company Overview 776.10 Becton, Dickinson and Company 786.10.1 Company Overview 786.11 ARKRAY, Inc. 786.11.1 Company Overview 786.12 Ypsomed Holding AG 796.12.1 Company Overview 79
  4. 4. 6.13 Terumo Corporation 796.13.1 Company Overview 797 Diabetes Care Devices Market Pipeline Products 808 Financial Deals Landscape 848.1 Partnerships 848.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 849 Recent Developments 859.1 Product News 859.1.1 Jul 23, 2008: BodyTels Blood Glucose Monitoring And Diabetes Management System,GlucoTel, Passes TNO Tests 8510 Appendix 8610.1 Definitions of Markets Covered in the Report 8710.1.1 Diabetes Care Devices 8710.2 Research Methodology 8910.3 Secondary Research 8910.4 Primary Research 9010.5 Models 9010.6 Forecasts 9110.7 Expert Panels 9110.8 GlobalData Consulting 9110.9 Currency Conversion 9110.10 Contact Us 9110.11 Disclaimer 921.1 List of TablesTable 1: Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Constant, 2004-201811Table 2: Diabetes Care Devices Market, Netherlands, Category Contribution (%), 2011 13Table 3: Diabetes Care Devices, Netherlands, Cross-Segment Analysis, 2004-2018 15Table 4: Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Constant, Historic,2004-2011 16Table 5: Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Constant, Forecast,2011-2018 18Table 6: Diabetes Care Devices, Netherlands, Company Share by Revenue ($m), USD Constant,2010-2011 20Table 7: Glucose Monitoring Market, Netherlands, Segment Contribution (%), 2011 23Table 8: Glucose Monitoring, Netherlands, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 25Table 9: Glucose Monitoring, Netherlands, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 27Table 10: Blood Glucose Meters, Netherlands, Revenue ($m*) USD Constant, by Sub-Segment,Historic, 2004-2011 29
  5. 5. Table 11: Blood Glucose Meters, Netherlands, Revenue ($m*) USD Constant, by Sub-Segment,Forecast, 2011-2018 31Table 12: Glucose Monitoring, Netherlands, Volume (Units) by Segment, Historic, 2004-2011 33Table 13: Glucose Monitoring, Netherlands, Volume (Units) by Segment, Forecast, 2011-2018 35Table 14: Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Historic, 2004-2011 36Table 15: Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2011-2018 37Table 16: Glucose Monitoring, Netherlands, Average Price ($), Historic, 2004-2011 38Table 17: Glucose Monitoring, Netherlands, Average Price ($), Forecast, 2011-2018 38Table 18: Glucose Monitoring, Netherlands, Distribution Share by Revenue ($m), USD Constant,2010-2011 39Table 19: Glucose Monitoring, Netherlands, Company Share by Revenue ($m), USD Constant,2010-2011 41Table 20: Insulin Delivery Market, Netherlands, Segment Contribution (%), 2011 44Table 21: Insulin Delivery, Netherlands, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 46Table 22: Insulin Delivery, Netherlands, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 48Table 23: Insulin Pens, Netherlands, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 50Table 24: Insulin Pens, Netherlands, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 52Table 25: Insulin Pumps, Netherlands, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 54Table 26: Insulin Pumps, Netherlands, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 56Table 27: Insulin Delivery, Netherlands, Volume (Units) by Segment, Historic, 2004-2011 58Table 28: Insulin Delivery, Netherlands, Volume (Units) by Segment, Forecast, 2011-2018 60Table 29: Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Historic, 2004-2011 62Table 30: Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2011-2018 64Table 31: Insulin Pumps, Netherlands, Volume (Units) by Sub-Segment, Historic, 2004-2011 65Table 32: Insulin Pumps, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2011-2018 66Table 33: Insulin Delivery, Netherlands, Average Price ($), Historic, 2004-2011 67Table 34: Insulin Delivery, Netherlands, Average Price ($), Forecast, 2011-2018 67Table 35: Insulin Delivery, Netherlands, Distribution Share by Revenue ($m), USD Constant,2010-2011 68Table 36: Insulin Delivery, Netherlands, Company Share by Revenue ($m), USD Constant, 2010-2011 70Table 37: Diabetes Care Devices Market Pipeline Products 80Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 84
  6. 6. 1.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 10Figure 2: Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Constant, 2004-201811Figure 3: Diabetes Care Devices Market, Netherlands, Revenue Mix ($m), 2011 12Figure 4: Diabetes Care Devices Market, Netherlands, Category Contribution (%), 2011 13Figure 5: Diabetes Care Devices, Netherlands, Cross-Segment Analysis, 2004-2018 14Figure 6: Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Constant, Historic,2004-2011 16Figure 7: Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Constant, Forecast,2011-2018 17Figure 8: Diabetes Care Devices, Netherlands, Company Share (%), 2011 19Figure 9: Glucose Monitoring, Market Segmentation 21Figure 10: Glucose Monitoring Market, Netherlands, Revenue Mix ($m), 2011 22Figure 11: Glucose Monitoring Market, Netherlands, Segment Contribution (%), 2011 23Figure 12: Glucose Monitoring, Netherlands, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 24Figure 13: Glucose Monitoring, Netherlands, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 26Figure 14: Blood Glucose Meters, Netherlands, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 28Figure 15: Blood Glucose Meters, Netherlands, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 30Figure 16: Glucose Monitoring, Netherlands, Volume (Units) by Segment, Historic, 2004-2011 32Figure 17: Glucose Monitoring, Netherlands, Volume (Units) by Segment, Forecast, 2011-2018 34Figure 18: Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Historic, 2004-2011 36Figure 19: Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2011-2018 37Figure 20: Glucose Monitoring, Netherlands, Company Share (%), 2011 40Figure 21: Insulin Delivery, Market Segmentation 42Figure 22: Insulin Delivery Market, Netherlands, Revenue Mix ($m), 2011 43Figure 23: Insulin Delivery Market, Netherlands, Segment Contribution (%), 2011 44Figure 24: Insulin Delivery, Netherlands, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 45Figure 25: Insulin Delivery, Netherlands, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 47Figure 26: Insulin Pens, Netherlands, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 49Figure 27: Insulin Pens, Netherlands, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 51Figure 28: Insulin Pumps, Netherlands, Revenue ($m) USD Constant, by Sub-Segment, Historic,
  7. 7. 2004-2011 53Figure 29: Insulin Pumps, Netherlands, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 55Figure 30: Insulin Delivery, Netherlands, Volume (Units) by Segment, Historic, 2004-2011 57Figure 31: Insulin Delivery, Netherlands, Volume (Units) by Segment, Forecast, 2011-2018 59Figure 32: Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Historic, 2004-2011 61Figure 33: Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2011-2018 63Figure 34: Insulin Pumps, Netherlands, Volume (Units) by Sub-Segment, Historic, 2004-2011 65Figure 35: Insulin Pumps, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2011-2018 66Figure 36: Insulin Delivery, Netherlands, Company Share (%), 2011 69Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),Netherlands Diabetes Care DevicesMarket, 2011 71Figure 38: Medtronic, Inc., Company Share (%),Netherlands Diabetes Care Devices Market, 201172Figure 39: Sanofi, Company Share (%),Netherlands Diabetes Care Devices Market, 2011 73Figure 40: Novo Nordisk A/S, Company Share (%),Netherlands Diabetes Care Devices Market,2011 74Figure 41: LifeScan, Inc., Company Share (%),Netherlands Diabetes Care Devices Market, 201175Figure 42: Eli Lilly and Company, Company Share (%),Netherlands Diabetes Care DevicesMarket, 2011 76Contact: sales@reportsandreports.com for more information.

×